Publicaciones en las que colabora con Damià Barceló Cullerés (19)

2022

  1. UHPLC-HRMS data from non-targeted screening for biotransformation products of cytostatic drug imatinib

    Data in Brief

2021

  1. A novel workflow utilizing open-source software tools in the environmental fate studies: The example of imatinib biotransformation

    Science of the Total Environment, Vol. 797

2018

  1. A case study to identify priority cytostatic contaminants in hospital effluents

    Chemosphere, Vol. 190, pp. 417-430

  2. Aerobic activated sludge transformation of vincristine and identification of the transformation products

    Science of the Total Environment, Vol. 610-611, pp. 892-904

2016

  1. Biodegradability of the anticancer drug etoposide and identification of the transformation products

    Environmental Science and Pollution Research, Vol. 23, Núm. 15, pp. 14706-14717

  2. Drugs of abuse, cytostatic drugs and iodinated contrast media in tap water from the Madrid region (central Spain): A case study to analyse their occurrence and human health risk characterization

    Environment International, Vol. 86, pp. 107-118

  3. First inter-laboratory comparison exercise for the determination of anticancer drugs in aqueous samples

    Environmental Science and Pollution Research, Vol. 23, Núm. 15, pp. 14692-14704

  4. Ozonation of hospital raw wastewaters for cytostatic compounds removal. Kinetic modelling and economic assessment of the process

    Science of the Total Environment, Vol. 556, pp. 70-79

  5. Reactivity of vinca alkaloids during water chlorination processes: Identification of their disinfection by-products by high-resolution quadrupole-Orbitrap mass spectrometry

    Science of the Total Environment, Vol. 544, pp. 635-644

  6. Toxicity of the mixture of selected antineoplastic drugs against aquatic primary producers

    Environmental Science and Pollution Research, Vol. 23, Núm. 15, pp. 14780-14790

2015

  1. Aerobic activated sludge transformation of methotrexate: Identification of biotransformation products

    Chemosphere, Vol. 119, pp. S42-S50

  2. Assessment of toxicity and genotoxicity of low doses of 5-fluorouracil in zebrafish (Danio rerio) two-generation study

    Water Research, Vol. 77, pp. 201-212

  3. Degradation of the anticancer drug erlotinib during water chlorination: Non-targeted approach for the identification of transformation products

    Water Research, Vol. 85, pp. 103-113

  4. Degradation of the cytostatic etoposide in chlorinated water by liquid chromatography coupled to quadrupole-Orbitrap mass spectrometry: Identification and quantification of by-products in real water samples

    Science of the Total Environment, Vol. 506-507, pp. 36-45

  5. Transformation of tamoxifen and its major metabolites during water chlorination: Identification and in silico toxicity assessment of their disinfection byproducts

    Water Research, Vol. 85, pp. 199-207

2014

  1. Cytostatic drugs and metabolites in municipal and hospital wastewaters in Spain: Filtration, occurrence, and environmental risk

    Science of the Total Environment, Vol. 497-498, pp. 68-77

  2. Study of the stability of 26 cytostatic drugs and metabolites in wastewater under different conditions

    Science of the Total Environment, Vol. 482-483, Núm. 1, pp. 389-398

2013

  1. Multianalyte determination of 24 cytostatics and metabolites by liquid chromatography-electrospray-tandem mass spectrometry and study of their stability and optimum storage conditions in aqueous solution

    Talanta, Vol. 116, pp. 290-299

  2. On-line solid phase extraction-liquid chromatography-tandem mass spectrometry for the determination of 17 cytostatics and metabolites in waste, surface and ground water samples

    Journal of Chromatography A, Vol. 1280, pp. 64-74